| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |